How much is enough? Assessing 30‐ versus 60‐day Timeline Followback stability in youth alcohol use patterns
Alcohol, Clinical and Experimental Research · 2025-11 · 49 (11) · 2619-2628
DOI: 10.1111/acer.70177 ↗Kurz gefasst
Fachartikel in der Zeitschrift Alcohol, Clinical and Experimental Research, online erschienen am 27.10.2025. Verfasst von Anna E Kirkland und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Psychiatry and Behavioral Sciences, Medical University of South Carolina, Charleston, South Carolina, USA. Hauptthemen laut MEDLINE: Alcohol Drinking, Underage Drinking. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 17 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NIAAA NIH HHS, National Institute on Alcohol Abuse and Alcoholism.
Abstract (Originalsprache)
Background
The variability of youth alcohol use is thought to necessitate longer Timeline Followback (TLFB) reporting windows to accurately capture alcohol use patterns. However, longer TLFB windows can increase burden for participants and study staff. This study assessed youth alcohol use patterns across two different 30‐day periods (TLFB days 1–30 and 31–60) to inform future research protocols.
Methods
Participants ( N = 481 with 504 visits, ages: 15–25) completed a shared intake to determine eligibility for numerous substance‐related studies. Alcohol consumption over the past 60 days was assessed using a modified TLFB that recorded total number of drinks, average drinks per day, average drinks per drinking day (DPDD), total number of drinking days, maximum number of drinks in a single day, and total number of binge drinking days (4+ drinks for females, 5+ drinks for males). TLFB data were divided into two 30‐day periods: the most recent (Days 1–30) and the more distal (Days 31–60). Analyses were conducted overall and within subgroups by sex, age (under 21 or 21+), presence of alcohol use disorder (AUD), and other substance use. Alcohol use patterns were assessed using Spearman correlations, Wilcoxon signed rank tests, and intraclass correlations (ICC) for test–retest reliability.
Results
All alcohol outcomes were significantly correlated between reporting windows ( p 's < 0.001). Alcohol use was significantly higher during the more recent reporting window (TLFB Days 1–30; p 's < 0.05), except for DPDD ( p = 0.58). Overall, the differences between reporting windows were small (on average, less than three total drinks and
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Psychiatry and Behavioral Sciences, Medical University of South Carolina, Charleston, South Carolina, USA.
- Department of Public Health Sciences, Medical University of South Carolina, Charleston, South Carolina, USA.
- The Matilda Centre for Research in Mental Health and Substance Use, University of Sydney, Sydney, New South Wales, Australia.
ORCID-Profile: Anna E Kirkland, Lindsay M Squeglia
Förderung
- NIAAA NIH HHS
- National Institute on Alcohol Abuse and Alcoholism
Zitieren
APA
Kirkland, A. E., Ferguson, P. L., Alcala, T. J., Mewton, L., Tomko, R. L., & Squeglia, L. M. (2025). How much is enough? Assessing 30‐ versus 60‐day Timeline Followback stability in youth alcohol use patterns. Alcohol, Clinical and Experimental Research, 49(11), 2619-2628. https://doi.org/10.1111/acer.70177
Vancouver
Kirkland AE, Ferguson PL, Alcala TJ, Mewton L, Tomko RL, Squeglia LM. How much is enough? Assessing 30‐ versus 60‐day Timeline Followback stability in youth alcohol use patterns. Alcohol, Clinical and Experimental Research. 2025;49(11):2619-2628. doi:10.1111/acer.70177
BibTeX
@article{Kirkland2025,
author = {Kirkland, Anna E and Ferguson, Pamela L and Alcala, Tirza J and Mewton, Louise and Tomko, Rachel L and Squeglia, Lindsay M},
title = {How much is enough? Assessing 30‐ versus 60‐day Timeline Followback stability in youth alcohol use patterns},
journal = {Alcohol, Clinical and Experimental Research},
year = {2025},
volume = {49},
number = {11},
pages = {2619--2628},
doi = {10.1111/acer.70177}
}
EUVIMED